These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17312474)

  • 1. Immunologic tolerance to skin allograft after graft-versus-host disease.
    Elias BG; Meunier DI; Squifflet JP; Marot L; Weynand B; VanWijck RR; Bayet B
    Plast Reconstr Surg; 2007 Mar; 119(3):40e-44e. PubMed ID: 17312474
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast media triggering cutaneous graft-versus-host disease.
    Vavricka SR; Halter J; Furrer K; Wolfensberger U; Schanz U
    Bone Marrow Transplant; 2002 Jun; 29(11):899-901. PubMed ID: 12080354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Graft vs host disease of the skin].
    Martín Ortega E
    Med Clin (Barc); 1990 Feb; 94(5):180-3. PubMed ID: 2325478
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous allografting and autografting of skin for ulcers in a bone marrow transplant patient.
    Kamei Y; Torii S; Hasegawa M; Toriyama K; Kodera Y
    Transplantation; 1993 Dec; 56(6):1530-1. PubMed ID: 8279030
    [No Abstract]   [Full Text] [Related]  

  • 5. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
    Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life.
    Ziemer M; Thiele JJ; Gruhn B; Elsner P
    J Am Acad Dermatol; 2004 Aug; 51(2):318-9. PubMed ID: 15280858
    [No Abstract]   [Full Text] [Related]  

  • 7. Acquired ichthyosis in bone marrow transplant recipients.
    Spelman LJ; Strutton GM; Robertson IM; Weedon D
    J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-vs-host disease.
    Tran K; Kaplan J; Kamino H; Latkowski JA
    Dermatol Online J; 2013 Dec; 19(12):20710. PubMed ID: 24365001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Ulcer by Cutaneous GvHD After Bone Marrow Transplantation Treated With Skin Allograft From HLA-Identical Donor: Case Report and Literature Review.
    Amendola F; Gazzola R; Lombardo M; Caminiti R; Dagna L; Baruffaldi-Preis FW
    Int J Low Extrem Wounds; 2016 Jun; 15(2):139-41. PubMed ID: 27009789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation].
    Baumeister RG; Riel KA; Kolb HJ
    Chirurg; 1990 Jun; 61(6):438-40. PubMed ID: 2364784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive hematochezia secondary to graft-versus-host disease and cytomegalovirus.
    Shabahang M; Pasquale MD; Bitterman P; Cirenza E; Spitzer T; Evans SR
    Am J Gastroenterol; 1994 Apr; 89(4):632-3. PubMed ID: 8147374
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease.
    Kim JB; Liakopoulou E; Watson JS
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1235-8. PubMed ID: 17509955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis post allogeneic bone marrow transplantation revisited.
    Koski SL; Mackey JR; Mackey DS
    Bone Marrow Transplant; 1998 Aug; 22(4):403-4. PubMed ID: 9722080
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cutaneous graft versus host disease].
    Aractingi S; Chosidow O; Gluckman E; Socié G
    Presse Med; 1995 Apr; 24(14):679-85. PubMed ID: 7770416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease.
    Tutschka PJ; Berkowitz SD; Tuttle S; Klein J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2668-73. PubMed ID: 3547945
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
    Tetteh HA
    J Surg Res; 2013 Aug; 183(2):544-5. PubMed ID: 22677610
    [No Abstract]   [Full Text] [Related]  

  • 17. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
    Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
    Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allogeneic bone marrow transplantation in acute and chronic myeloid leukemia: role of conditioning and of graft-versus-host disease in the long-term maintenance of remission].
    Bacigalupo A; Frassoni F; Van Lint MT; Occhini D; Gualandi F; Lamparelli T; Vitale V; Scarpati D; Clavio M; Marmont AM
    Haematologica; 1989 Oct; 74(5 Suppl):425-32. PubMed ID: 2512226
    [No Abstract]   [Full Text] [Related]  

  • 19. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.